Location: Home
  • search
  • go
  • Relate News
  • 7/29/2025Merck Faces China Headwinds as Gardasil Pause Drags on Q2 Results
  • 7/28/2025Everest Secures $200M in Share Placement While Epirium Bio Pursues $55...
  • 7/28/2025SystImmune Files First ARC IND as ADC Pipeline Hits Double Digits
  • 7/28/2025China Approves BMS's Opdivo + Yervoy Combo for PD-L1 Positive mNSCLC
  • 7/28/2025China Medical System Gains NMPA Acceptance for Alzheimer's Drug ZUNVEY...
  • 7/26/2025Ambroxol Hydrochloride Drops Reclassified as OTC Drug in China
  • 7/26/2025China's Basic Medical Insurance Fund Reports Surplus in H1/2025
  • 7/26/2025Recent Official and Executive Moves
  • 7/25/2025China Launches Nationwide Pilot Program for Smart Medical Insurance Ov...
  • 7/24/2025Pfizer Finalizes 3SBio Deal, Prepares Global Phase 3 Launch for BsAb S...
  • 7/24/2025Roche Sees Strong China Pharma Growth in H12025
  • 7/23/2025SAMR Orders Simcere to Reverse Unnotified Merger Over Competition, Pri...
  • 7/22/2025Chimigen Raises ~CNY 170M to Advance Cancer and HepB Vaccines
  • 7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...
  • 7/22/2025Simcere Zaiming Secures U.S. FDA Approval for IND of FGFR2b-Targeted A...
  • 7/22/2025Novatim Licenses Global Rights for Dual-Target CAR-T Therapy KQ-2003 t...
  • 7/22/2025Livzon's Dual Inhibitor LZM‑012 Positive in Global Phase III Psoriasi...
  • 7/22/2025PharmaDJ's China Biopharma Tracker – June 2025 (PharmaDJ)
  • 7/21/2025Novo Nordisk, Fangzhou Partner on AI-Powered Diabetes, Obesity Care
  • 7/18/2025Chinese Biotechs Drive Hong Kong IPO Boom in H12025
  • 7/18/2025China Launches 11th Round of VBP, Covering 55 Medicines with CNY 44B ...
  • 7/18/2025CMS Launches Secondary Listing in Singapore to Fuel Regional Expansion
  • 7/18/2025Novartis CEO Highlights China Momentum in Q2 2025 Earnings Call
  • 7/18/2025China Approves Nation's First Recombinant Human Albumin Injection Deri...
  • 7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...
  • 7/18/2025China Approves First Homegrown Oral Anti‑Influenza Drug by Zenshine P...
  • 7/18/2025Recent Executive Moves
  • 7/17/2025China Accepts Amgen and ONC Marketing Submission for Imdelltra in ES-S...
  • 7/17/2025I‑Mab Deepens Bet on CLDN18.2 Bispecific by Acquiring Bridge Health
  • 7/15/2025Sino Biopharma Acquires Merck's Chinese Partner LaNova Medicines in $9...
  • Page:12/373 Total number of articles:11190: [First][<<] [10] [11] [12] [13] [14] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group